Cargando…
Establishment of an in vitro model for analyzing mitochondrial ultrastructure in PRKN-mutated patient iPSC-derived dopaminergic neurons
Mitochondrial structural changes are associated with the regulation of mitochondrial function, apoptosis, and neurodegenerative diseases. PRKN is known to be involved with various mechanisms of mitochondrial quality control including mitochondrial structural changes. Parkinson’s disease (PD) with PR...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7986497/ https://www.ncbi.nlm.nih.gov/pubmed/33757554 http://dx.doi.org/10.1186/s13041-021-00771-0 |
_version_ | 1783668456105705472 |
---|---|
author | Yokota, Mutsumi Kakuta, Soichiro Shiga, Takahiro Ishikawa, Kei-ichi Okano, Hideyuki Hattori, Nobutaka Akamatsu, Wado Koike, Masato |
author_facet | Yokota, Mutsumi Kakuta, Soichiro Shiga, Takahiro Ishikawa, Kei-ichi Okano, Hideyuki Hattori, Nobutaka Akamatsu, Wado Koike, Masato |
author_sort | Yokota, Mutsumi |
collection | PubMed |
description | Mitochondrial structural changes are associated with the regulation of mitochondrial function, apoptosis, and neurodegenerative diseases. PRKN is known to be involved with various mechanisms of mitochondrial quality control including mitochondrial structural changes. Parkinson’s disease (PD) with PRKN mutations is characterized by the preferential degeneration of dopaminergic neurons in the substantia nigra pars compacta, which has been suggested to result from the accumulation of damaged mitochondria. However, ultrastructural changes of mitochondria specifically in dopaminergic neurons derived from iPSC have rarely been analyzed. The main reason for this would be that the dopaminergic neurons cannot be distinguished directly among a mixture of iPSC-derived differentiated cells under electron microscopy. To selectively label dopaminergic neurons and analyze mitochondrial morphology at the ultrastructural level, we generated control and PRKN-mutated patient tyrosine hydroxylase reporter (TH-GFP) induced pluripotent stem cell (iPSC) lines. Correlative light-electron microscopy analysis and live cell imaging of GFP-expressing dopaminergic neurons indicated that iPSC-derived dopaminergic neurons had smaller and less functional mitochondria than those in non-dopaminergic neurons. Furthermore, the formation of spheroid-shaped mitochondria, which was induced in control dopaminergic neurons by a mitochondrial uncoupler, was inhibited in the PRKN-mutated dopaminergic neurons. These results indicate that our established TH-GFP iPSC lines are useful for characterizing mitochondrial morphology, such as spheroid-shaped mitochondria, in dopaminergic neurons among a mixture of various cell types. Our in vitro model would provide insights into the vulnerability of dopaminergic neurons and the processes leading to the preferential loss of dopaminergic neurons in patients with PRKN mutations. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13041-021-00771-0. |
format | Online Article Text |
id | pubmed-7986497 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-79864972021-03-24 Establishment of an in vitro model for analyzing mitochondrial ultrastructure in PRKN-mutated patient iPSC-derived dopaminergic neurons Yokota, Mutsumi Kakuta, Soichiro Shiga, Takahiro Ishikawa, Kei-ichi Okano, Hideyuki Hattori, Nobutaka Akamatsu, Wado Koike, Masato Mol Brain Methodology Mitochondrial structural changes are associated with the regulation of mitochondrial function, apoptosis, and neurodegenerative diseases. PRKN is known to be involved with various mechanisms of mitochondrial quality control including mitochondrial structural changes. Parkinson’s disease (PD) with PRKN mutations is characterized by the preferential degeneration of dopaminergic neurons in the substantia nigra pars compacta, which has been suggested to result from the accumulation of damaged mitochondria. However, ultrastructural changes of mitochondria specifically in dopaminergic neurons derived from iPSC have rarely been analyzed. The main reason for this would be that the dopaminergic neurons cannot be distinguished directly among a mixture of iPSC-derived differentiated cells under electron microscopy. To selectively label dopaminergic neurons and analyze mitochondrial morphology at the ultrastructural level, we generated control and PRKN-mutated patient tyrosine hydroxylase reporter (TH-GFP) induced pluripotent stem cell (iPSC) lines. Correlative light-electron microscopy analysis and live cell imaging of GFP-expressing dopaminergic neurons indicated that iPSC-derived dopaminergic neurons had smaller and less functional mitochondria than those in non-dopaminergic neurons. Furthermore, the formation of spheroid-shaped mitochondria, which was induced in control dopaminergic neurons by a mitochondrial uncoupler, was inhibited in the PRKN-mutated dopaminergic neurons. These results indicate that our established TH-GFP iPSC lines are useful for characterizing mitochondrial morphology, such as spheroid-shaped mitochondria, in dopaminergic neurons among a mixture of various cell types. Our in vitro model would provide insights into the vulnerability of dopaminergic neurons and the processes leading to the preferential loss of dopaminergic neurons in patients with PRKN mutations. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13041-021-00771-0. BioMed Central 2021-03-23 /pmc/articles/PMC7986497/ /pubmed/33757554 http://dx.doi.org/10.1186/s13041-021-00771-0 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Methodology Yokota, Mutsumi Kakuta, Soichiro Shiga, Takahiro Ishikawa, Kei-ichi Okano, Hideyuki Hattori, Nobutaka Akamatsu, Wado Koike, Masato Establishment of an in vitro model for analyzing mitochondrial ultrastructure in PRKN-mutated patient iPSC-derived dopaminergic neurons |
title | Establishment of an in vitro model for analyzing mitochondrial ultrastructure in PRKN-mutated patient iPSC-derived dopaminergic neurons |
title_full | Establishment of an in vitro model for analyzing mitochondrial ultrastructure in PRKN-mutated patient iPSC-derived dopaminergic neurons |
title_fullStr | Establishment of an in vitro model for analyzing mitochondrial ultrastructure in PRKN-mutated patient iPSC-derived dopaminergic neurons |
title_full_unstemmed | Establishment of an in vitro model for analyzing mitochondrial ultrastructure in PRKN-mutated patient iPSC-derived dopaminergic neurons |
title_short | Establishment of an in vitro model for analyzing mitochondrial ultrastructure in PRKN-mutated patient iPSC-derived dopaminergic neurons |
title_sort | establishment of an in vitro model for analyzing mitochondrial ultrastructure in prkn-mutated patient ipsc-derived dopaminergic neurons |
topic | Methodology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7986497/ https://www.ncbi.nlm.nih.gov/pubmed/33757554 http://dx.doi.org/10.1186/s13041-021-00771-0 |
work_keys_str_mv | AT yokotamutsumi establishmentofaninvitromodelforanalyzingmitochondrialultrastructureinprknmutatedpatientipscderiveddopaminergicneurons AT kakutasoichiro establishmentofaninvitromodelforanalyzingmitochondrialultrastructureinprknmutatedpatientipscderiveddopaminergicneurons AT shigatakahiro establishmentofaninvitromodelforanalyzingmitochondrialultrastructureinprknmutatedpatientipscderiveddopaminergicneurons AT ishikawakeiichi establishmentofaninvitromodelforanalyzingmitochondrialultrastructureinprknmutatedpatientipscderiveddopaminergicneurons AT okanohideyuki establishmentofaninvitromodelforanalyzingmitochondrialultrastructureinprknmutatedpatientipscderiveddopaminergicneurons AT hattorinobutaka establishmentofaninvitromodelforanalyzingmitochondrialultrastructureinprknmutatedpatientipscderiveddopaminergicneurons AT akamatsuwado establishmentofaninvitromodelforanalyzingmitochondrialultrastructureinprknmutatedpatientipscderiveddopaminergicneurons AT koikemasato establishmentofaninvitromodelforanalyzingmitochondrialultrastructureinprknmutatedpatientipscderiveddopaminergicneurons |